PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 9:35 AM ET

Sponsor Check › Person

TK
No photo found yet (own website and image search run after this page is viewed)

Tim Kutzkey

Named as an officer, director or promoter on SEC Form D filings · CA · Apr 23, 2010 → Mar 27, 2026

20deals (issuers)
$2.41Breported sold
395investors
33Form D filings
2010–2026years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:15 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Tim Kutzkey is listed as an executive officer and director on 33 SEC Form D filings by 20 issuers between Apr 2010 and Mar 2026. Largest by amount reported sold: Column Group V, LP (San Francisco, CA — pooled investment fund — 2022; $600M reported sold to 99 investors), Column Group Opportunity III, LP (San Francisco, CA — pooled investment fund — 2022; $600M reported sold to 100 investors), COLUMN GROUP III-A, LP (San Francisco, CA — pooled investment fund — 2016; $270.5M reported sold to 32 investors), COLUMN GROUP III, LP (San Francisco, CA — pooled investment fund — 2016; $239.5M reported sold to 39 investors), Carmot Therapeutics Inc. (Berkeley, CA — biotechnology — 2010–2023; $160.7M reported sold to 25 investors) and 15 more (all listed below).

What this means That is a lot of deals — 20 separate companies raised money with this person listed as executive officer and director, over about 16 years. Across those companies the filings report $2.41B sold in total.

Listed alongside Peter Svennilson (17 shared filings), David Goeddel (13 shared filings), Leo Guthart (8 shared filings), Arnold Kriegstein (6 shared filings), Cory Nicholas (5 shared filings) and 32 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Tim. Each name links to their own page.

The issuers belong to 2 sponsor groups: Column (17 issuers, $2.41B reported sold, 2010–2025) and Surrozen (2 issuers, $126.4M reported sold, 2020–2025).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 33 public filings for Tim Kutzkey and found 11 differences, 1 worth asking the sponsor about: Tim Kutzkey appears on 7 deals that stopped filing before reaching their target; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Tim Kutzkey has not run yet — it is joining a line of 36,480 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:15 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Tim Kutzkey..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:15 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

11 differences found between the filings for Tim Kutzkey — 1 worth asking about (compared 33 filings on Oct 24, 2026)

Worth asking · May 6, 2011 – Apr 10, 2024

Tim Kutzkey appears on 7 deals that stopped filing before reaching their target

Site Tx, Inc. (last filing Apr 10, 2024; $6,000,000 sold of $15,000,000); Column Group IV-A, LP (last filing Dec 11, 2019; $0 sold of $25,000,000); Column Group IV, LP (last filing Dec 11, 2019; $0 sold of $700,000,000); Ponoi Capital II, LP (last filing Mar 6, 2018; $0 sold of $100,000,000); PONOI CAPITAL, LP (last filing Jun 7, 2017; $0 sold of $150,000,000); COLUMN GROUP III, LP (last filing Apr 27, 2016; $239,535,000 sold of $500,000,000); and 1 more. Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

Site Tx, Inc. — PartnerFacts page ↗Column Group IV-A, LP — PartnerFacts page ↗Column Group IV, LP — PartnerFacts page ↗Ponoi Capital II, LP — PartnerFacts page ↗
Sources
Note · Apr 7, 2010 – Jun 23, 2020

4 Form Ds were filed more than 15 days after the first sale

Form D filed 19 days after the first sale — Surrozen, Inc. · Form D filed 19 days after the first sale — NEURONA THERAPEUTICS, INC · Form D filed 19 days after the first sale — Carmot Therapeutics Inc. · Form D filed 16 days after the first sale — Carmot Therapeutics Inc.

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Jun 23, 2020 ↗Surrozen, Inc. — PartnerFacts page ↗Form D · Feb 27, 2018 ↗NEURONA THERAPEUTICS, INC — PartnerFacts page ↗
Sources
Note · Feb 16, 2011 – Apr 10, 2024

10 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Site Tx, Inc. (latest filing Apr 10, 2024) · No amendment in the last 12 months on an offering that may still be open — NEURONA THERAPEUTICS, INC (latest filing Dec 23, 2022) · No amendment in the last 12 months on an offering that may still be open — Surrozen, Inc. (latest filing Jun 23, 2020) · No amendment in the last 12 months on an offering that may still be open — NEURONA THERAPEUTICS, INC (latest filing Nov 25, 2019) · No amendment in the last 12 months on an offering that may still be open — NEURONA THERAPEUTICS, INC (latest filing Feb 27, 2018) · and 5 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Apr 10, 2024 ↗Site Tx, Inc. — PartnerFacts page ↗Form D/A · Dec 23, 2022 ↗NEURONA THERAPEUTICS, INC — PartnerFacts page ↗
Sources
Note · Nov 25, 2019 – Mar 29, 2021

Tim Kutzkey's role changed at NEURONA THERAPEUTICS, INC: executive officer, director → director

The Nov 25, 2019 filing lists Tim Kutzkey as executive officer, director; the Mar 29, 2021 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Nov 25, 2019 ↗Form D · Mar 29, 2021 ↗Tim Kutzkey — PartnerFacts page ↗NEURONA THERAPEUTICS, INC — PartnerFacts page ↗
Sources
Note · Feb 25, 2011 – Mar 27, 2026

6 offerings changed their target amount between filings

Offering amount changed between filings — NGM Bio Holdings, Inc. · Offering amount changed between filings — NEURONA THERAPEUTICS, INC · Offering amount changed between filings — NEURONA THERAPEUTICS, INC · Offering amount lowered between filings — COLUMN GROUP III-A, LP · Offering amount lowered between filings — COLUMN GROUP III, LP · and 1 more

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D (earlier) · Jul 17, 2024 ↗Form D/A (later) · Mar 27, 2026 ↗NGM Bio Holdings, Inc. — PartnerFacts page ↗Form D (earlier) · Mar 29, 2021 ↗
Sources
Note · Feb 29, 2016 – Apr 27, 2016

Minimum investment changed between filings — COLUMN GROUP III-A, LP

The Feb 29, 2016 filing lists a minimum of $10,000,000; the Apr 27, 2016 Form D/A lists $50,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Feb 29, 2016 ↗Form D/A (later) · Apr 27, 2016 ↗COLUMN GROUP III-A, LP — PartnerFacts page ↗
Sources
Note · Feb 29, 2016 – Apr 27, 2016

Minimum investment changed between filings — COLUMN GROUP III, LP

The Feb 29, 2016 filing lists a minimum of $10,000,000; the Apr 27, 2016 Form D/A lists $25,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Feb 29, 2016 ↗Form D/A (later) · Apr 27, 2016 ↗COLUMN GROUP III, LP — PartnerFacts page ↗
Sources
Note · Apr 23, 2010 – Jun 7, 2017

Tim Kutzkey is written 2 different ways on the filings

listed as "Tim Kutzkey" on 29 filings (from Apr 23, 2010), and "TIM Kutzkey, PHD" on 4 filings (from Jun 7, 2017).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Apr 23, 2010 ↗Form D · Jun 7, 2017 ↗Tim Kutzkey — PartnerFacts page ↗
Sources
Note · Dec 23, 2014 – Feb 27, 2018

Reported revenue range changed between filings — NEURONA THERAPEUTICS, INC

"Not Applicable" (Dec 23, 2014); then "Decline to Disclose" (Feb 27, 2018).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Dec 23, 2014 ↗Form D · Feb 27, 2018 ↗NEURONA THERAPEUTICS, INC — PartnerFacts page ↗
Sources
Note · Oct 15, 2015 – Aug 2, 2024

Same name, different state: "Tim Kutzkey" (NY) is a separate record

This page covers filings where the address state is CA. A separate record, "Tim Kutzkey" with address state NY, is listed on 3 filings — most recently by NILO Therapeutics, Inc. (Aug 2, 2024). Both records have filings in the same period (Oct 15, 2015 to Aug 2, 2024).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Tim Kutzkey (NY) — PartnerFacts page ↗Form D · Aug 2, 2024 ↗NILO Therapeutics, Inc. — PartnerFacts page ↗Tim Kutzkey (CA) — this page ↗
Sources
Note · Jul 14, 2011 – Aug 8, 2022

5 address changes between filings

Address moved from San Francisco, CA to Berkeley, CA — Carmot Therapeutics Inc. · Address moved from San Francisco, CA to South San Francisco, CA — NEURONA THERAPEUTICS, INC · Address moved from South San Francisco, CA to San Francisco, CA — NEURONA THERAPEUTICS, INC · Address moved from San Francisco, CA to South San Francisco, CA — NEURONA THERAPEUTICS, INC · Address moved from San Francisco, CA to Dallas, TX — Peloton Therapeutics, Inc.

What this means Businesses move. If you were told one city and the forms say another, ask which is current.

Form D · Aug 25, 2017 ↗Form D · Aug 8, 2022 ↗Carmot Therapeutics Inc. — PartnerFacts page ↗Form D · Nov 25, 2019 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

0 of 29 offerings report sales commissions; 0 report finder's fees; 1 reports proceeds to related persons totalling $5,000,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Mar 27, 2026 D/A
NGM Bio Holdings, Inc.
File 021-519045
$0$0$0None listed on this filingEDGAR ↗
Dec 16, 2025 D
Column Group VI, LP
File 021-567039
$0$0$0None listed on this filingEDGAR ↗
Dec 16, 2025 D
Column Group Opportunity IV, LP
File 021-567040
$0$0$0None listed on this filingEDGAR ↗
Apr 4, 2025 D
NEURONA THERAPEUTICS, INC
File 021-543006
$0$0$0None listed on this filingEDGAR ↗
Apr 10, 2024 D
Site Tx, Inc.
File 021-510275
$0$0$0None listed on this filingEDGAR ↗
Feb 13, 2024 D
NEURONA THERAPEUTICS, INC
File 021-505128
$0$0$0None listed on this filingEDGAR ↗
Feb 13, 2024 D
Column Group-Neuro II, LP
File 021-505164
$0$0$0None listed on this filingEDGAR ↗
Jun 6, 2023 D
Carmot Therapeutics Inc.
File 021-483450
$0$0$0None listed on this filingEDGAR ↗
Dec 23, 2022 D/A
NEURONA THERAPEUTICS, INC
File 021-393804
$0$0$0None listed on this filingEDGAR ↗
Dec 8, 2022 D
Column Group SPV I, LP
File 021-466953
$0$0$0None listed on this filingEDGAR ↗
Aug 8, 2022 D
Carmot Therapeutics Inc.
File 021-455238
$0$0$0None listed on this filingEDGAR ↗
Jun 16, 2022 D
Column Group V, LP
File 021-449432
$0$0$0None listed on this filingEDGAR ↗
Jun 16, 2022 D
Column Group Opportunity III, LP
File 021-449435
$0$0$0None listed on this filingEDGAR ↗
May 14, 2021 D
Column Group-Neuro, LP
File 021-399536
$0$0$0None listed on this filingEDGAR ↗
Jun 23, 2020 D
Surrozen, Inc.
File 021-369446
$0$0$0None listed on this filingEDGAR ↗
Dec 11, 2019 D
Column Group IV-A, LP
File 021-355337
$0$0$0None listed on this filingEDGAR ↗
Dec 11, 2019 D
Column Group IV, LP
File 021-355333
$0$0$0None listed on this filingEDGAR ↗
Nov 25, 2019 D
NEURONA THERAPEUTICS, INC
File 021-354176
$0$0$0None listed on this filingEDGAR ↗
Mar 6, 2018 D
Ponoi Capital II, LP
File 021-307049
$0$0$5,000,000 (est.)
The General Partner is entitled to a management fee and a carried interest.
None listed on this filingEDGAR ↗
Feb 27, 2018 D
NEURONA THERAPEUTICS, INC
File 021-306460
$0$0$0None listed on this filingEDGAR ↗
Aug 25, 2017 D
Carmot Therapeutics Inc.
File 021-293514
$0$0$0None listed on this filingEDGAR ↗
Jun 7, 2017 D
PONOI CAPITAL, LP
File 021-288186
$0$0$0 (est.)
THE GENERAL PARTNER IS ENTITLED TO A CARRIED INTEREST
None listed on this filingEDGAR ↗
Dec 28, 2016 D/A
NEURONA THERAPEUTICS, INC
File 021-230717
$0$0$0None listed on this filingEDGAR ↗
Apr 27, 2016 D/A
COLUMN GROUP III, LP
File 021-258236
$0$0$0
THE GENERAL PARTNER IS ENTITLED TO A CARRIED INTEREST. THE INVESTMENT MANAGER IS ENTITLED TO A MANAGEMENT FEE. THE CARRIED INTEREST AND MANAGEMENT FEE ARE FULLY DISCUSSED IN THE ISSUER?S CONFIDENTIAL OFFERING MATERIALS.
None listed on this filingEDGAR ↗
Apr 27, 2016 D/A
COLUMN GROUP III-A, LP
File 021-258238
$0$0$0 (est.)
THE GENERAL PARTNER IS ENTITLED TO A CARRIED INTEREST. THE INVESTMENT MANAGER IS ENTITLED TO A MANAGEMENT FEE. THE CARRIED INTEREST AND MANAGEMENT FEE ARE FULLY DISCUSSED IN THE ISSUER?S CONFIDENTIAL OFFERING MATERIALS.
None listed on this filingEDGAR ↗
Oct 4, 2012 D/A
Peloton Therapeutics, Inc.
File 021-162891
$0$0$0None listed on this filingEDGAR ↗
Jul 17, 2012 D
Carmot Therapeutics Inc.
File 021-181381
$0$0$0None listed on this filingEDGAR ↗
May 6, 2011 D/A
Cyterix Pharmaceuticals Inc.
File 021-155865
$0$0$0None listed on this filingEDGAR ↗
Apr 23, 2010 D
Carmot Therapeutics Inc.
File 021-141033
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 20

Every issuer that named Tim Kutzkey on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

NB
Biotechnology

NGM Bio Holdings, Inc.

South San Francisco, CA · Mar 27, 2026
  • Mar 27, 2026 · D/A · $142,039,949 sold of $142,039,949 · 26 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $142M from 26 investors (100% of the $142M target) as of the latest filing. Tim is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CG
Pooled Investment Fund · group: Column

Column Group Opportunity IV, LP

San Francisco, CA · Dec 16, 2025
  • Dec 16, 2025 · D · $0 sold of $600,000,000 · 0 investors · min. No minimum reported · role: Executive Officer (Managing Member of the General Partner of the General Partner) EDGAR ↗

No sales reported yet as of the latest filing. Tim is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CG
Pooled Investment Fund · group: Column

Column Group VI, LP

San Francisco, CA · Dec 16, 2025
  • Dec 16, 2025 · D · $0 sold of $600,000,000 · 0 investors · min. No minimum reported · role: Executive Officer (Managing Member of the General Partner of the General Partner) EDGAR ↗

No sales reported yet as of the latest filing. Tim is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

NT
Biotechnology · group: Column

NEURONA THERAPEUTICS, INC

South San Francisco, CA · Dec 23, 2014 → Apr 4, 2025 · 8 filings
  • Apr 4, 2025 · D · $101,711,423 sold of $101,711,423 · 46 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 13, 2024 · D · $119,999,974 sold of $119,999,974 · 35 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 23, 2022 · D/A · $72,008,582 sold of $91,598,577 · 21 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 29, 2021 · D · $28,328,611 sold of $40,000,000 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 25, 2019 · D · $15,030,288 sold of $49,999,999 · 9 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Feb 27, 2018 · D · $10,044,329 sold of $20,044,332 · 6 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Dec 28, 2016 · D/A · $28,680,743 sold of $30,300,001 · 13 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Dec 23, 2014 · D · $7,644,339 sold of $24,300,000 · 11 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $120M from 46 investors (100% of the $101.7M target) as of the latest filing. Tim is listed as director, executive officer on 8 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

ST
Other Health Care

Site Tx, Inc.

San Francisco, CA · Apr 10, 2024
  • Apr 10, 2024 · D · $6,000,000 sold of $15,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $6M from 1 investor (40% of the $15M target) as of the latest filing. Tim is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CG
Pooled Investment Fund · group: Column

Column Group-Neuro II, LP

San Francisco, CA · Feb 13, 2024
  • Feb 13, 2024 · D · $100,000,000 sold of $100,000,000 · 3 investors · min. No minimum reported · role: Executive Officer (Managing Member of the General Partner of the General Partner) EDGAR ↗

Raised $100M from 3 investors (100% of the $100M target) as of the latest filing. Tim is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CT
Biotechnology

Carmot Therapeutics Inc.

Berkeley, CA · Apr 23, 2010 → Jun 6, 2023 · 5 filings
  • Jun 6, 2023 · D · $149,999,802 sold of $149,999,802 · 25 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 8, 2022 · D · $160,671,809 sold of $160,671,809 · 15 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 25, 2017 · D · $10,795,943 sold of $15,374,764 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 17, 2012 · D · $500,159 sold of $1,200,317 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 23, 2010 · D · $1,549,999 sold of $1,549,999 · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $160.7M from 25 investors (100% of the $150M target) as of the latest filing. Tim is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CG
Pooled Investment Fund · group: Column

Column Group SPV I, LP

San Francisco, CA · Dec 8, 2022
  • Dec 8, 2022 · D · $10,543,500 sold of $10,543,500 · 1 investors · min. No minimum reported · role: Executive Officer (Managing Member of the General Partner of the General Partner) EDGAR ↗

Raised $10.5M from 1 investor (100% of the $10.5M target) as of the latest filing. Tim is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CG
Pooled Investment Fund · group: Column

Column Group Opportunity III, LP

San Francisco, CA · Jun 16, 2022
  • Jun 16, 2022 · D · $600,000,000 sold of $600,000,000 · 100 investors · min. No minimum reported · role: Executive Officer (Managing Member of the General Partner of the General Partner) EDGAR ↗

Raised $600M from 100 investors (100% of the $600M target) as of the latest filing. Tim is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CG
Pooled Investment Fund · group: Column

Column Group V, LP

San Francisco, CA · Jun 16, 2022
  • Jun 16, 2022 · D · $600,000,000 sold of $600,000,000 · 99 investors · min. No minimum reported · role: Executive Officer (Managing Member of the General Partner of the General Partner) EDGAR ↗

Raised $600M from 99 investors (100% of the $600M target) as of the latest filing. Tim is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CG
Pooled Investment Fund · group: Column

Column Group-Neuro, LP

San Francisco, CA · May 14, 2021
  • May 14, 2021 · D · $100,000,000 sold of $100,000,000 · 4 investors · min. No minimum reported · role: Executive Officer (Managing Member of the General Partner of the General Partner) EDGAR ↗

Raised $100M from 4 investors (100% of the $100M target) as of the latest filing. Tim is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

S
Biotechnology · group: Surrozen

Surrozen, Inc.

South San Francisco, CA · Jun 23, 2020
  • Jun 23, 2020 · D · $49,999,991 sold of $50,000,000 · 12 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $50M from 12 investors (100% of the $50M target) as of the latest filing. Tim is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CG
Pooled Investment Fund · group: Column

Column Group IV-A, LP

San Francisco, CA · Dec 11, 2019
  • Dec 11, 2019 · D · $0 sold of $25,000,000 · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

No sales reported yet as of the latest filing. Tim is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CG
Pooled Investment Fund · group: Column

Column Group IV, LP

San Francisco, CA · Dec 11, 2019
  • Dec 11, 2019 · D · $0 sold of $700,000,000 · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

No sales reported yet as of the latest filing. Tim is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

PC
Pooled Investment Fund · group: Column

Ponoi Capital II, LP

San Francisco, CA · Mar 6, 2018
  • Mar 6, 2018 · D · $0 sold of $100,000,000 · 0 investors · min. $500,000 · role: Executive Officer EDGAR ↗

No sales reported yet as of the latest filing. Tim is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

PC
Pooled Investment Fund · group: Column

PONOI CAPITAL, LP

San Francisco, CA · Jun 7, 2017
  • Jun 7, 2017 · D · $0 sold of $150,000,000 · 0 investors · min. $1,000,000 · role: Executive Officer EDGAR ↗

No sales reported yet as of the latest filing. Tim is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CG
Pooled Investment Fund · group: Column

COLUMN GROUP III-A, LP

San Francisco, CA · Apr 27, 2016
  • Apr 27, 2016 · D/A · $270,510,000 sold of $270,510,000 · 32 investors · min. $50,000 · role: Executive Officer EDGAR ↗

Raised $270.5M from 32 investors (100% of the $270.5M target) as of the latest filing. Tim is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CG
Pooled Investment Fund · group: Column

COLUMN GROUP III, LP

San Francisco, CA · Apr 27, 2016
  • Apr 27, 2016 · D/A · $239,535,000 sold of $239,535,000 · 39 investors · min. $25,000 · role: Executive Officer EDGAR ↗

Raised $239.5M from 39 investors (100% of the $239.5M target) as of the latest filing. Tim is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

PT
Biotechnology · group: Column

Peloton Therapeutics, Inc.

Dallas, TX · Jul 14, 2011 → Oct 4, 2012 · 2 filings
  • Oct 4, 2012 · D/A · $11,700,000 sold of $20,000,000 · 4 investors · min. No minimum reported · role: Executive Officer, Director (Acting CEO and Secretary) EDGAR ↗
  • Jul 14, 2011 · D · $2,000,000 sold of $20,000,000 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $11.7M from 4 investors (59% of the $20M target) as of the latest filing. Tim is listed as executive officer, director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

CP
Biotechnology

Cyterix Pharmaceuticals Inc.

Redwood City, CA · Feb 25, 2011 → May 6, 2011 · 2 filings
  • May 6, 2011 · D/A · $1,500,000 sold of $7,700,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 25, 2011 · D · $900,000 sold of $7,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $1.5M from 3 investors (19% of the $7.7M target) as of the latest filing. Tim is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (1)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Tim Kutzkey — NY, 2 issuers, Oct 15, 2015 → Aug 2, 2024 · no shared issuer

People around Tim 37

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

PS
No photo found yet (own website and image search run after this page is viewed)
Person

Peter Svennilson

Executive Officer, Director · 17 shared filings (16 issuers) · also on 5 other issuers

Peter Svennilson is on 21 issuers in total — a repeat sponsor. Their page lists every one.

DG
No photo found yet (own website and image search run after this page is viewed)
Person

David Goeddel

Director, Executive Officer · 13 shared filings (11 issuers) · also on 9 other issuers

David Goeddel is on 20 issuers in total — a repeat sponsor. Their page lists every one.

LG
No photo found yet (own website and image search run after this page is viewed)
Person

Leo Guthart

Director · 8 shared filings (1 issuer) · also on 7 other issuers

Leo Guthart is on 8 issuers in total — a repeat sponsor. Their page lists every one.

AK
No photo found yet (own website and image search run after this page is viewed)
Person

Arnold Kriegstein

Director · 6 shared filings (1 issuer)

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

SH
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen Hauser

Director · 5 shared filings (1 issuer)

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

CN
No photo found yet (own website and image search run after this page is viewed)
Person

Cory Nicholas

Executive Officer, Director, Promoter · 5 shared filings (1 issuer)

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

SH
No photo found yet (own website and image search run after this page is viewed)
Person

Stig K. Hansen

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

RT
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Tjian

Director · 4 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

DE
No photo found yet (own website and image search run after this page is viewed)
Person

Daniel A. Erlanson

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

AT
No photo found yet (own website and image search run after this page is viewed)
Person

Aetna Wun Trombley

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

EW
No photo found yet (own website and image search run after this page is viewed)
Person

Erica Whittaker

Director · 3 shared filings (1 issuer)

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

BM
No photo found yet (own website and image search run after this page is viewed)
Person

Brad Margus

Director · 3 shared filings (1 issuer)

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

DD
No photo found yet (own website and image search run after this page is viewed)
Person

DAVID V GOEDDEL PH D

Executive Officer · 2 shared filings (2 issuers) · also on 2 other issuers

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

SE
No photo found yet (own website and image search run after this page is viewed)
Person

Steven Everett

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

James Stutz

Executive Officer · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

TG
No photo found yet (own website and image search run after this page is viewed)
Person

Timothy Garnett

Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

RK
No photo found yet (own website and image search run after this page is viewed)
Person

Ray Kelleher

Director · 2 shared filings (1 issuer)

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

MP
No photo found yet (own website and image search run after this page is viewed)
Person

Magnus Persson

Director · 1 shared filing (1 issuer)

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

RP
No photo found yet (own website and image search run after this page is viewed)
Person

Roger M. Perlmutter

Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

BR
No photo found yet (own website and image search run after this page is viewed)
Person

Brett Ringle

Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

John Creecy

Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

DG
No photo found yet (own website and image search run after this page is viewed)
Person

Dave Goeddel

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

JJ
No photo found yet (own website and image search run after this page is viewed)
Person

John Josey

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

LL
No photo found yet (own website and image search run after this page is viewed)
Person

Larry Lasky

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

RT
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Tijan

Director · 1 shared filing (1 issuer)

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

AM
No photo found yet (own website and image search run after this page is viewed)
Person

Alexander Marson

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

HT
No photo found yet (own website and image search run after this page is viewed)
Person

Heather Turner

Executive Officer, Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

AB
No photo found yet (own website and image search run after this page is viewed)
Person

Anna Berkenblit

Director · 1 shared filing (1 issuer)

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

HV
No photo found yet (own website and image search run after this page is viewed)
Person

Harold Varmus

Director · 1 shared filing (1 issuer)

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

CP
No photo found yet (own website and image search run after this page is viewed)
Person

Craig Parker

Executive Officer, Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

AD
No photo found yet (own website and image search run after this page is viewed)
Person

Anne Phillips, M.D.

Director · 1 shared filing (1 issuer)

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

SD
No photo found yet (own website and image search run after this page is viewed)
Person

Stig K. Hansen, Ph.D.

Director · 1 shared filing (1 issuer)

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

EW
No photo found yet (own website and image search run after this page is viewed)
Person

Erica Whitaker

Director · 1 shared filing (1 issuer)

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

AS
No photo found yet (own website and image search run after this page is viewed)
Person

Aadit Shah

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

DB
No photo found yet (own website and image search run after this page is viewed)
Person

Diana Peng Bockus

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

MB
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Brown

Director · 1 shared filing (1 issuer) · also on 12 other issuers

Michael Brown is on 13 issuers in total — a repeat sponsor. Their page lists every one.

MB
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Brown

Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Tim Kutzkey. Their page shows their other deals.

The team behind the deals

C
Sponsor group

Column

17 issuers · 28 filings · $2.41B reported sold · 2010–2025

One team, 17 deal companies. Tim Kutzkey is listed on 15 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Tim Kutzkey.

S
Sponsor group

Surrozen

2 issuers · 3 filings · $126.4M reported sold · 2020–2025

One team, 2 deal companies. Tim Kutzkey is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Tim Kutzkey.

Same business address

31 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

A person is never an adviser firm. 8 of the 20 issuers this person is listed on match a Form ADV adviser (searched 24,962 advisers as of Oct 2, 2026): Column Group SPV I, LP, Column Group Opportunity III, LP, Column Group V, LP, Column Group-Neuro, LP, Column Group IV, LP, Ponoi Capital II, LP, PONOI CAPITAL, LP, COLUMN GROUP III, LP.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Tim Kutzkey by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 20 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Tim Kutzkey is listed on: none on file. No website or social profile named in Column Group Opportunity III, LP's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #152,171 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (San Francisco, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗California — find the county court ↗Los Angeles Superior Court case search ↗Texas re:SearchTX court records ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

California Secretary of State business search ↗Texas Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Tim Kutzkey appears on a new Form D, or when a court case or SEC action is matched to them. See plans →